AR007738A1 - THE USE OF A LEPTINE SENSITIZER OR A PHARMACEUTICALLY ACCEPTABLE DERIVATIVE OF IT FOR THE MANUFACTURING OF A MEDICATION USEFUL FOR THE TREATMENT AND / OR PROPHYLAXIS OF LEPTIN RESISTANCE AND / OR STATES ASSOCIATED WITH LEPTIN RESISTANCE AND / OR - Google Patents
THE USE OF A LEPTINE SENSITIZER OR A PHARMACEUTICALLY ACCEPTABLE DERIVATIVE OF IT FOR THE MANUFACTURING OF A MEDICATION USEFUL FOR THE TREATMENT AND / OR PROPHYLAXIS OF LEPTIN RESISTANCE AND / OR STATES ASSOCIATED WITH LEPTIN RESISTANCE AND / ORInfo
- Publication number
- AR007738A1 AR007738A1 ARP970103143A ARP970103143A AR007738A1 AR 007738 A1 AR007738 A1 AR 007738A1 AR P970103143 A ARP970103143 A AR P970103143A AR P970103143 A ARP970103143 A AR P970103143A AR 007738 A1 AR007738 A1 AR 007738A1
- Authority
- AR
- Argentina
- Prior art keywords
- leptin resistance
- pharmaceutically acceptable
- sensitizer
- prophylaxis
- treatment
- Prior art date
Links
- 102000016267 Leptin Human genes 0.000 title abstract 4
- 108010092277 Leptin Proteins 0.000 title abstract 4
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 title abstract 4
- 229940039781 leptin Drugs 0.000 title abstract 4
- 239000003814 drug Substances 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000011321 prophylaxis Methods 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 title abstract 2
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
El uso de un sensibilizador a la leptina o un derivado farmacéuticamente aceptable del mismo para la manufactura de un medicamento útil para eltratamiento y/o profilaxis de la resistencia a la leptina y/o sus complicaciones, enmamíf eros humanos y no humanos, comprendiendo dichomedicamento una cantidad eficaz, no tóxica y farmacéuticamente aceptable de un sensibilizador a la leptina o uno de sus derivados farmacéuticamente aceptablesy un vehículo farmacéuticamenteaceptable.The use of a leptin sensitizer or a pharmaceutically acceptable derivative thereof for the manufacture of a medicament useful for the treatment and / or prophylaxis of leptin resistance and / or its complications, in human and non-human mammals, the drug comprising a effective, non-toxic and pharmaceutically acceptable amount of a sensitizer to leptin or one of its pharmaceutically acceptable derivatives and a pharmaceutically acceptable vehicle.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9614751.7A GB9614751D0 (en) | 1996-07-12 | 1996-07-12 | Novel treatment |
| GBGB9614740.0A GB9614740D0 (en) | 1996-07-12 | 1996-07-12 | Novel treatment |
| GBGB9616412.4A GB9616412D0 (en) | 1996-08-05 | 1996-08-05 | Novel treatment |
| GBGB9616409.0A GB9616409D0 (en) | 1996-08-05 | 1996-08-05 | Novel treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR007738A1 true AR007738A1 (en) | 1999-11-10 |
Family
ID=51929773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970103143A AR007738A1 (en) | 1996-07-12 | 1997-07-14 | THE USE OF A LEPTINE SENSITIZER OR A PHARMACEUTICALLY ACCEPTABLE DERIVATIVE OF IT FOR THE MANUFACTURING OF A MEDICATION USEFUL FOR THE TREATMENT AND / OR PROPHYLAXIS OF LEPTIN RESISTANCE AND / OR STATES ASSOCIATED WITH LEPTIN RESISTANCE AND / OR |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR007738A1 (en) |
-
1997
- 1997-07-14 AR ARP970103143A patent/AR007738A1/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT1264696B1 (en) | PHARMACEUTICAL FORMS INTENDED FOR ORAL ADMINISTRATION ABLE TO RELEASE ACTIVE SUBSTANCES AT A CONTROLLED AND DIFFERENTIATED SPEED | |
| CY1107643T1 (en) | TREATMENT OF DIABETES WITH A THIAZOLIDINODIONE AND METFORMIN | |
| CO5050297A1 (en) | USE OF PEG-IFN-ALFA AND RIBAVIRINE FOR THE TREATMENT OF CHRONIC HEPATITIS C | |
| AR008444A1 (en) | EMPLOYMENT OF LEPTINE ANTAGONISTS FOR THE TREATMENT OF INSULIN RESISTANCE IN TYPE II DIABETES | |
| ES2177780T3 (en) | MEDICATIONS FOR THE TREATMENT OF AUTOIMMUNE DISEASES USING INTERFERON TAU. | |
| AR033342A1 (en) | A TOPIC OR INTRANASAL OTHICAL COMPOSITION TO TREAT OTICO PAIN AND THE TOPICAL USE OF KAPA OPIOID AGONISTS TO TREAT OTICO PAIN | |
| ITMI911299A0 (en) | PHARMACEUTICAL COMPOSITIONS ACTIVE IN THE THERAPY OF SLEEP DISORDERS INCLUDING MELATONIN OR ONE OF ITS DERIVATIVES IN ASSOCIATION WITH A BENZODIAZEPE DERIVATIVE | |
| AR026610A1 (en) | A PIRROLIDINACETAMIDE DERIVATIVE ONLY OR IN COMBINATION FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | |
| ES2192839T3 (en) | TIMOSINA BETA 4 OXIDADA. | |
| AR023715A1 (en) | PHARMACEUTICAL COMPOSITION FOR A SUBJECT WHO NEEDS AN ELEVATION OF THE CONTENT OF NAD INTRACELLULAR, AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINE TO INCREASE THE PROTECTIVE CELLULAR RESPONSES TO GENOTOXIC STRESS IN THE SKIN | |
| DE60121988D1 (en) | COMBINATION THERAPY WITH ANTIDIBLE AND ANTICONVULSIVE AGENTS | |
| CR7049A (en) | EMPLOYMENT OF FLUMAZENYL IN THE DEVELOPMENT OF A MEDICATION FOR THE TREATMENT OF ALCOHOL DEPENDENCE | |
| EE04493B1 (en) | Cyclopentene derivatives, a pharmaceutical composition containing them and their use as a medicament for the treatment of motilin receptor-related disorders in humans | |
| DE60320034D1 (en) | TREATMENT OF MASTITIS WITH A COMBINATION OF PREDNISOLONE AND CEPHALOSPORIN | |
| PT1150704E (en) | MELAGATRAN FOR THE TREATMENT OF INFLAMMATION | |
| ATE133680T1 (en) | OLIGOSACCHARIDE DERIVATIVES AND THEIR USE IN REMEDIES | |
| AR022621A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING DEOXIPEGANINE FOR THE TREATMENT OF NICOTINE DEPENDENCE | |
| YU39598A (en) | The use of dulloxetine and its pharmaceutical composition | |
| AR008025A1 (en) | PHARMACEUTICAL COMBINATION OF A THIAZOLIDINDIONA AND AN INSULIN SECRETOGOGUE | |
| ES2181915T3 (en) | CTLA-8 IN COMBINATION WITH G-CSF AND IL-6, AND USE OF CTLA-8 TO TREAT INFECTIONS. | |
| ES2191908T3 (en) | 4-AMINOPIRROL (3,2-D) PYRIMIDINS AS ANTAGONISTS OF THE NEUROPEPTIDE RECEPTOR. | |
| AR013352A1 (en) | USE OF AN INSULIN SENSITIZER AND AN ANTI-HYPERGLYCEMIC AGENT FOR THE PREPARATION OF A MEDICATION FOR THE TREATMENT OF DIABETES MELLITUS AND CONDITIONS ASSOCIATED WITH IT AND A PHARMACEUTICAL COMPOSITION. | |
| TR200101336T2 (en) | Combinations with a beta-agonist and another antidiabetic agent | |
| EE200200605A (en) | Use of a Substituted Acryloyldistamycin Derivative in the manufacture of a medicament for the treatment of tumors associated with high levels of glutathione | |
| AR245587A1 (en) | DEVICE TO ADMINISTER VETERINARY MEDICINES. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |